LBA23 EPIK-P1: Retrospective chart review study of patients (pts) with PIK3CA-related Overgrowth Spectrum (PROS) who have received alpelisib (ALP) as part of a compassionate use programme

Authors:
  • GCG. Canaud
    G. Canaud
  • JGJ.C. López Gutiérrez
    J.C. López Gutiérrez
  • AIA. Irvine
    A. Irvine
  • NAN. Ankrah
    N. Ankrah
  • APA. Papadimitriou
    A. Papadimitriou
  • ARA. Ridolfi
    A. Ridolfi
  • DAD.M. Adams
    D.M. Adams

Abstract
No abstract available
Funding Information
  • Novartis Pharmaceuticals Corporation